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The phosPharylaCon t)f cpittrcli~l~~pccifle eytokrrarin (CX) 8 and I# was rrudird in the human relonie cell line tIT29, Mcrnbelic lnbclliny of e111l~ 
with orlbaphoaphale rcaulrcd in phorphorylrtion efcytokcralins g/l8 on xerinc reaiduro. When phorbol i\CC[Ute WIIY added IQ lrbcllcd cells, a 2.2, 
fold inere#ue in CKL/IB phasphw lrklling WIIJ noled, wherr‘ur inrrraxing inlr#ccllul#r CAMP levels using forakolin or &BwAMP rhawcd no 
signitknnl change in CK. phoophorylntion. CKal/l8 WCN ulsa phosphorylutcd by oddcd PKC in rhc prerencc af(y-*aPJATP. 7’ryptir pdptidc map 
rntrlysis of the phorphorylutcd CKlZ tpceicr showed that (rea!rnent sfcellr with &BraAMP or phorbol tvxfnte generared LI phosghopleptidc not 
xccn in control txllr. In Contras& tryptic pcpridr maps of phosphorylakd CK18 showed nu dixcernubld iflcrrnccr. Our redullt suppart u role for 
PK@ in the phesphorylalian of cpithclisl cytokcrruins, with sonic phospharytarion &co being modulated by CAMP dcpendenr protein kinrsc. 
CytokeroGn phaapharylarion; Protein kinctrc C; Phorbol IICCIIW 
11 INTRODUCTION 
Intermediate filaments (IF) are a heterogeneous 
group of proteins that form an important part of the 
cycoskeleton and nuclear envelope of most eukaryocic 
cells ((l-3) for reviews). The 5 major types of IF show 
organelle (e.g. type V lamins) or tissue specificity (e.g. 
types I and II cytokeratins) depending on their consti- 
tuent structural domains [l ,a]. Cycokeratins, which en- 
compass approximately 30 different proteins, are ex- 
pressed primarily in epithelial cells and are considered a
marker for epithelial cell differentiation [4,§]. They 
form obligate non-covalent heteropolymers by the in- 
teraction of an acidic type I keratin with a neutral/basic 
type II keratin, As a group, cytokeratins undergo post- 
translational modification including O-linked glycosy- 
lation [6,7] and phosphorylation on serine residues 
[S-l 11. 
Although phosphorylation of several of the cyco- 
keratin chains has been reported [8-l 11, the kinascs chat 
are involved in their phosphorylation remain sketchy. 
Some in vitro evidence suggests that CAMP dependent 
protein kinase can phosphorylate hoof cytokeratins 
[lo], human cycokeratin 13 [9], and human keratins 1, 
10 and 11 IS]. This is supported by the presence of 
multiple potential CAMP dependent protein kinase sites 
in several of the cytokeratins that have been studied [S]. 
Wowever, the effect of agents that increase intracellular 
CAMP levels on CK phosphorylation has been variable. 
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For example, dibutyryl CAMP and isoproterenol in- 
creased the phosphorylation of CK13 2- and 5-fold 
respectively, but no effect was noted for CKS [9]. It was 
therefore suggested that other kinases may also play a 
role in CK phosphorylation although the nature of 
these kinases has not been studied. 
Protein kinase C (PKC) is a serine kinase with at Ieasc 
7 subspecies chat regulate multiple cellular events 
([12-141 for reviews), The role of PKC in cytokeratin 
phosphorylation has not been studied although PKC 
has been shown to play a role in the phosphorylation of 
other intermediate filament proteins such as lamin B 
[15]. In addition, PKC associates with several cyto- 
skeletal components [l&17] and may consequently 
phosphorylate cytoskeletal proteins. In this report, we 
used agents that modulate the activity of CAMP depen- 
dent protein kinase and PKC to ask if these 2 kinases 
play a role in cytokeratin 8 and 18 phosphorylation. 
2. MATERIALS AND METWOBS 
2. I. Muterids 
Phorbol 12”myristate 13sacetate (PMA), 4 rY-phorbol, ionomycin, 
forskolin, %bromo-CAMP, staurosporine, and anti-epithelial 
cyrokeratin (anti-cytokeratin 8 and 18) antibody termed CK5 were ob- 
tained from Sigma. Other materials used were: BAPTA/AM and 
Pansorbin (Calbiochem); carrier-free 13*P]phosphoric acid and 
[$‘P]ATP (3000 Ci/mmol) (New England Nuclear); CAMP ‘*‘I 
detection kit (Amersham); PVDF membranes (Immobolin P, 
Millipore). PKC-f was a generous gift from Dr Berta Strulovici 
(Syntex Research, Palo Alto, CA). HT29 cells (human colon 
adenocarcinoma cell line) were grown in RPM! 1640 media sup- 
plemented with 10% fetal calf serum, penicillin (lOOpg/ml) and strep- 
tomycin (100 pg/rnl). 
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Fig. 1, Cytokeratins 8 and lg are recognized by MAb L2Al and are phosphorylated on serinc residues. lmmunoprecipitates of CK8 and 18 were 
obtained from [“P]orthophosphate labclled HT29 cells after metabolic labelling for 2 h in phosphate-free media, Panels A-C show 2D analysis 
with horizontal arrows indicating isoelectric focusing (IEF) and vertical arrows indicating SDS electrophoresis (basic peptides are to the left). Panel 
B shows an autoradiograph of the dried Coomassie stained gel shown in panel A. Panel C represents a separate CK immunoprecipitate analyzed 
by a 213 gel followed by Western blotting, Panels A-C also include immunoprecipitates that were analyzed only in the second dimension (horizontal 
bracket) to allow easier identification of the 2D spots. Panel D shows results of phosphoamino acid analysis of a pooled mixture of CK 8 and 18. 
PS, phosphoserine; PT, phosphothrconine; PY, phosphotyrosine. 
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3. RESULTS 
MAb L2Al immunoprecipitated 2 major bands cor- 
responding to CK8 and CK18 as seen on Coomassic 
blue staining in Fig. 1A. The 3rd prominent middle 
band may correspond to CK7 but was not investigated 
further. The pf of CK8 and 18 shown in Fig. 1 was 
6.0-6.2 and 5.6-5.8 respectively and was similar to rhat 
rcportcd by others [4]. Both CK8 and 18 were phos- 
phorylatcd (Fig. 1 B), and the pcpridc chains recognized 
by the MAb by Western blotting (Fig. lC), correspond- 
ed to the phosphorylated species (autoradiograph of 
Fig. lC, not shown), Analysis of the phosphorylated 
residues on CK8 and 18 revealed that phosphorylation 
occurred mainly on serine residues with less than 5% of 
the radioactivity associated with threoninc residue?; 
(Fig. 1D). 
We then asked if protein kinase C or CAMP depen,- 
dent protein kinase plays a role in the phosphorylation 
of CK8/18 by using agents that modulate the function 
of these kinases. Increasing intracellular CAMP levels 
using forskolin or 8-Br-CAMP resulted in increasing irl’* 
tracellular CAMP levels by 30-200 fold (Fig. 2A). These 
elevations in CAMP levels did nor result in any signif’i- 
cant change in the level of phosphorylation of either 
CK8 or 18 (Fig. 2A and Table I). In contrast, the addi- 
tion of phorbol acetate to cells labelled with [32P]or- 
thophosphate increased the level of CK8/18 
phosphorylation by 2-fold (mean 2.2, n = 7) (Fig. 2B), 
Staurosporine, a PKC inhibitor [24], caused a 60% 
decrease in CK phosphorylation; whereas 4@-phorbol, 
ionomycin and the cell permeable calcium ion chelator 
BAPTA/AM [25] had no significant effect on CK 
phosphorylation (Table I), 
The increase in CK phosphorylation in the presence 
of phorbol acetate is consistent with PKC acting as the 
kinase. The lack of effect of calcium mobilization by 
ionomycin or chelation by BAPTNAM suggested that 
202 
Relatlvo [CAMP]: 1 1 25 22 31 22 207 
B 
116 - 
63- 
66 - 
v 
45--w* 
31 - 
- - -91c 
f’ig. 2. Phospborytation of cyiokcrafins 8118 in Ihc prescncc of for- 
skolin, 8.WcAMP, PMA and by PKC-c. ‘The figure shows 
autoractiograms of: (A) Cells in duplicn~cs were cithcr tabelted with 
orthophosphatc or incubaIcd under the same conditions as tabcllcd 
cetts. Eorskolin (in DMSO, lO~tl/ml added) or R-BrwcAMP (in H20) 
were added for the indicated timepoints to duplicate dishes, followed 
by immunoprecipitation and SDS/PAGE (labclted cells) or measurc- 
ment of CAMP lcvuls (unlabcltcd duplicate), Lane 2 shows im- 
munoprecipitates from control cet,!s, to which IO pl of DMSO was 
ddded. The measured CAMP corresponding to lane 1 was 75 frnol per 
1 x 10” HT29 cells. (B) Cytokeratin phosphorylation with or without 
added PMA (200 r&ml). Also shown are unlabelect cytokcratin im- 
munoprecipitatcs in the presence of [y-“P]ATP and added PKGc 
(lane e) or without PKC-c (lane d). 
the involved kinase may bk calcium independent. We 
therefore tested if CK8/18 can serve as an in vitro 
substrate for PKC-6, a calcium independent isoform of 
PKC [l%, 131. As shown in Fig. 2B, PKC-E phos- 
phorylated both CK 8 and 18 which were isolated from 
I-IT29 cells using the L2Al-sepharose coupled MAb. 
Fig. 3. Tryptic phosphopcptide analysis of phosphate labelled CK8 and 18 in the presence of PMA and X.Br-CAMP. Individual polypeptides cor- 
responding to CK8 or CKl8 were electroeluted from SDS-polyacrylamide gels and processed for peptide mapping as described in Section 2. Ap- 
proximately 1200 cpm of each trypsin-digested polypeptide was loaded onto the cellulose plates followed by elcctrophoresis in the horizontal axis 
and chromatography in the vertical axis. Exposure of the autoradiograph was for 3-6 days. 
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phorylwtion caf CK8Pl8 after an increase in lntraocllrrlac 
CAMP levels, R rn6re mtatlc ditkrenec wus abacrvcd !?3r 
CW after dctniled ~~~~y~i$ usiing tryptie peptide map- 
ping. Earlier studies rhowed that increa\rinp in- 
tracellular CAMP lcvcl~ manifesfcd variable dit’fcrcnc~~ 
in the level ot’cytakwatin phosphoryiutian, depending 
on tire eytakerntin that war studied [9J. Mawever, thctc 
studier did not examine individual tryptic peptides. In= 
tcrcsGn#, the same peptlde appeared after increasing 
CAMP levels as after stimulation wirh PM& It remains 
to bc determined if the ~me rerine or thr~nninc residue 
is being phosphorplated in ttrc pwcnee of fhe different 
stirr;ulating agents, and whether the phor;pb+!rylntion 
involves a single or n enscttde of kinases. A role for 
cAMP dependent protein kinasc in the phosphnrylscion 
of CK$/l8 is not surprising iven that CK8 contains a 
total of 59 scrinc residues with 6 sequence motifs (basic- 
X-scr) representing potcrrtial cAMP protein kinase 
phosphorylation sites [26], wheras CK18 contains 37 
scrinc residues with basic-x-set’ motifs [ tS]. 
Previous studies had suggested that CK phosphoryln- 
tion involved other kineses in addition to cAMP dcpen- 
dcnc protein kinasc (8,9], although the nature of these 
kinases has not been investigated, Our data support a 
role for PKC in cytokeratin phosphorytation. This is 
based on enhancement of the phosphorylation level in 
the presence of PMA and inhibition of phosphorylation 
in the presence of staurosporinc, Furthcrmorc, 
CKs8/18 arc good phosphorylation substrates when 
mixed with PKC+. Although other studies arc required, 
it appears that within the PKC family, PKC-E is a possi- 
b!e cczndidatc a(; a protein kinase involved in cytokerslcin 
phosphorylation, This hypothesis I’s based on the Iack 
of effect of the intracetlular calcium modulators 
ionomycin and BAPTA/AM on cytokeratin phos- 
phorylation. To this end, HT29 cells contain significant 
levels of immunoreactive PKC-c as determined by 
Western blotting using an anti-PKC-Lc specific antibody 
(Berta Strulovici, personal communication). 
Other indirect evidence also supports a role far PKC 
in the phosphoryfation of cytoskcletal component pro- 
teins, For example, activation of PKC by bryostatin 
resulted in its translocation to the nuclear envelope and 
phosphorylation of the nuclear envelope intermediate 
filament protein lamin B [I§]. In addition, the calcium 
dependent PKC-a appears to associate with the 
cytoskeletal focal contact proteins vinculin and talin, 
which in turn mediate the attachment of microfilaments 
with the plasma membrane [17-J. 
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